アプタマーの世界市場レポート 2024年

アプタマーの市場規模は近年急激に拡大しています。2023年の21億6,000万米ドルから2024年には26億8,000万米ドルへと、CAGR23.8％で拡大します。過去の期間に観察された成長は、高特異性結合剤への需要、治療の可能性の認識、個別化医療へのアプローチの増加、様々な治療分野における潜在的用途の探求、抗体の代替品としてのアプタマーの出現、診断用ポイントオブケア（POC）機器におけるアプタマーの利用など、様々な要因に起因しています。これらの要素は、過去中に成長軌道を形成する上で重要な役割を果たしました。

2023年のアプタマー市場で最大の地域は北米でした。アプタマー市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東、アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のアプタマー市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のアプタマー市場規模実績と成長、2018～2023年
• 世界のアプタマー市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のアプタマー市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• DNAアプタマー
• XNAアプタマー
• RNAアプタマー
• 世界のアプタマー市場、技術別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• SELEX
• Xアプタマー
• マラステクニック
• 世界のアプタマー市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 治療薬の開発
• 研究開発
• 診断
• その他
• 世界のアプタマー市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 製薬会社とバイオテクノロジー会社
• 学術と政府の研究機関
• 陰極線オシロスコープ
• その他

第7章 地域と国の分析

• 世界のアプタマー市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のアプタマー市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アプタマー市場の競合情勢
• アプタマー市場の企業プロファイル
  • Aptamer Group Limited
  • SomaLogic Inc.
  • Aptamer Sciences Inc.
  • Aptagen LLC
  • NeoVentures Biotechnology Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

Aptamers Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aptamers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aptamers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aptamers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: DNA Aptamers; XNA Aptamers; RNA Aptamers
• 2) By Technology: SELEX; X Aptamer; Maras Technique
• 3) By Application: Therapeutics Development; Research and Development; Diagnostic; Other Applications
• 4) By End User: Pharmaceutical and Biotechnology Companies; Academic and Government Research Institutes; Cathode-Ray Oscilloscope; Other End Users
• Companies Mentioned: Aptamer Group Limited; SomaLogic Inc.; Aptamer Sciences Inc.; Aptagen LLC; NeoVentures Biotechnology Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Aptamers are short synthetic single-stranded oligonucleotides designed to fold into specific structures and bind to target antigens, which can include proteins, molecules, peptides, cells, and tissues. They serve as molecular recognition tools for their respective targets.

There are various types of aptamers, including DNA aptamers, XNA aptamers, and RNA aptamers. DNA aptamers are specific deoxyribonucleic acid (DNA) oligonucleotides capable of binding with high affinity and specificity to target antigens such as peptides, small molecules, cells, proteins, and tissues. They find applications in the design of drug delivery systems. Technologies like SELEX (Systematic Evolution of Ligands by Exponential Enrichment), X-Aptamer, and MARAS (Mirror-Image Aptamer Reverse Selection) techniques are utilized in therapeutic development, research and development, diagnostics, and other applications. Various end users, including pharmaceutical and biotechnology companies, academic and government research institutes, and diagnostic laboratories, employ aptamers for their diverse applications.

The aptamers market research report is one of a series of new reports from The Business Research Company that provides aptamers market statistics, including aptamers industry global market size, regional shares, competitors with an aptamers market share, detailed aptamers market segments, market trends, and opportunities, and any further data you may need to thrive in the aptamers industry. This aptamers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aptamers market size has grown exponentially in recent years. It will grow from $2.16 billion in 2023 to $2.68 billion in 2024 at a compound annual growth rate (CAGR) of 23.8%. The growth observed in the historical period can be attributed to various factors, including the demand for high-specificity binders, recognition of therapeutic potential, an increase in personalized medicine approaches, exploration of potential applications in various therapeutic areas, the emergence of aptamers as alternatives to antibodies, and the utilization of aptamers in diagnostic point-of-care (POC) devices. These elements collectively played a significant role in shaping the growth trajectory during the historic period.

The aptamers market size is expected to see exponential growth in the next few years. It will grow to $6.42 billion in 2028 at a compound annual growth rate (CAGR) of 24.5%. The anticipated growth in the forecast period can be attributed to several factors, including increasing investments in life sciences, expansion in drug development activities, growth in cancer research initiatives, the demand for rapid detection in emergency settings, advancements in aptamer selection techniques, and regulatory support. Major trends expected in the forecast period include advancements in SELEX (Systematic Evolution of Ligands by Exponential Enrichment) technology, increasing applications of aptamers in diagnostics, continued investments in aptamer research, technological integration with nanotechnology, and initiatives focused on awareness and education in the field of aptamers. These trends are poised to significantly impact and shape the landscape of aptamer applications in the coming years.

The anticipated surge in chronic respiratory diseases stands as a driving force behind the projected growth of the aptamers market. Chronic respiratory ailments involve the narrowing and swelling of airways, often accompanied by excessive mucus production, resulting in breathing difficulties, coughing, shortness of breath, and wheezing during exhalation. Aptamers play a pivotal role in identifying the respiratory syncytial virus (RSV), aiding in early disease detection and facilitating treatment. For instance, as of May 2021, projections shared by the Asthma and Allergy Foundation of America indicated that the number of Americans afflicted with asthma would exceed 25 million. Consequently, the escalating prevalence of chronic respiratory diseases emerges as a prime catalyst propelling the aptamers market's growth.

The escalating emphasis on personalized medicine is poised to drive the trajectory of the aptamers market. Personalized medicine entails tailored medical interventions aligning with individual patient characteristics, encompassing factors like genetics, lifestyle, and environment to enhance the efficacy and precision of healthcare delivery. Aptamers in the realm of Personalized Medicine function as customizable molecular tools for targeted diagnostics and therapies, exhibiting precise binding capabilities to specific molecules within individual patients. Notably, in 2021, as per The Personalized Medicine Coalition, the FDA's CDER approved 50 new molecular entities (NMEs), with 17 (35%) classified as personalized medicines by the Coalition. This surge in approvals for personalized medicines underscores a significant driver propelling the aptamers market forward.

Technological innovations stand out as a pivotal trend gaining momentum within the aptamers market. Key industry players are introducing novel technologies, exemplified by the creation of artificial DNA aptamers, leveraging adaptable and seamless technology to fortify their market positions. For instance, in May 2021, NEC Corporation, a multinational information technology and electronics corporation based in Japan, engineered artificial DNA aptamers with the capacity to bind to the novel COVID-19 (SARS-CoV-2). Utilizing adaptable and seamless technology, these aptamers can target the virus by identifying the three-dimensional structure of the receptor-binding domain (RBD), establishing a robust bond to immobilize the virus and prevent infection.

Prominent players within the aptamers market are spearheading the launch of innovative reagents like Optimer-Fc to tackle challenges prevalent in the immunohistochemistry (IHC) sector. Optimer-Fc represents a groundbreaking reagent designed specifically for automating immunohistochemistry workflows. For instance, in March 2023, UK-based biotech company Aptamer Group plc introduced Optimer-Fc, aimed at revolutionizing automated immunohistochemistry workflows, thereby effectively addressing challenges inherent in the IHC market. The company strategically collaborates with leading IHC firms, conducts meticulous validation of Optimer-Fc's performance, and orchestrates trials in partnership with top-tier pharmaceutical entities. Serving as an alternative to antibodies, Optimer-Fc seamlessly integrates Optimer binders into existing workflows, offering heightened precision and selectivity for disease biomarkers within IHC applications. This innovation assumes significance particularly amid patent expirations for IHC antibodies, presenting a patentable solution to meet evolving market needs.

In a significant development during May 2022, Epicore Biosystems, a US-based digital health and wearable solutions company, executed the acquisition of Eccrine Systems, incorporating its advanced aptamer-based sweat sensing technology into Epicore's array of wearable microfluidic solutions. The acquisition encompasses Eccrine Systems, renowned for its wearable sensor technology and electrochemical aptamer-based technology, enabling the quantification of selected biomarkers within sweat samples. This strategic move bolsters Epicore's sensor technology portfolio, enhancing its capabilities in developing wearable solutions and amplifying its proficiency in leveraging aptamer-based technologies for monitoring targeted biomarkers.

Major companies operating in the aptamers market report are Aptamer Group Limited, SomaLogic Inc., Aptamer Sciences Inc., Aptagen LLC, NeoVentures Biotechnology Inc., Aptus Biotech, Base Pair Biotechnologies Inc., AMS Biotechnology Ltd., Vivonics Inc., TriLink Biotechnologies LLC, Noxxon Pharma SE, AM Biotechnologies LLC, Raptamer Discovery Group, Kaneka Corporation, Novaptech Inc., Maravai Lifesciences Inc., Bio-Techne Corporation, Creative Biolabs Inc., IBA Lifesciences GmbH, Aptabharat Innovations Pvt. Ltd., Profacgen Biotech Inc., Medi GmbH & Co. KG, Pure Biologics Sp. z o.o., Oak BioSciences Inc., Ophthotech Corporation, Novartis AG, NeoNeuro SAS, CAGE Bio Inc., TAGCyx Biotechnologies Inc., AstraZeneca plc, GlyTech Inc., GC Biopharma Corp., Achiko AG, Agilent Technologies Inc., IVERIC bio Inc.

North America was the largest region in the aptamers market in 2023. The regions covered in the aptamers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aptamers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aptamers market includes revenues earned by entities by providing RNA profiling and detecting cells, viruses, sugars, and antibodies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Aptamers Market Characteristics

3. Aptamers Market Trends And Strategies

4. Aptamers Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Aptamers Market Size and Growth

• 5.1. Global Aptamers Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Aptamers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Aptamers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Aptamers Market Segmentation

• 6.1. Global Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• DNA Aptamers
• XNA Aptamers
• RNA Aptamers
• 6.2. Global Aptamers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• SELEX
• X Aptamer
• Maras Technique
• 6.3. Global Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Therapeutics Development
• Research and Development
• Diagnostic
• Other Applications
• 6.4. Global Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical and Biotechnology Companies
• Academic and Government Research Institutes
• Cathode-Ray Oscilloscope
• Other End Users

7. Aptamers Market Regional And Country Analysis

• 7.1. Global Aptamers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Aptamers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Aptamers Market

• 8.1. Asia-Pacific Aptamers Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Aptamers Market

• 9.1. China Aptamers Market Overview
• 9.2. China Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Aptamers Market

• 10.1. India Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Aptamers Market

• 11.1. Japan Aptamers Market Overview
• 11.2. Japan Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Aptamers Market

• 12.1. Australia Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Aptamers Market

• 13.1. Indonesia Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Aptamers Market

• 14.1. South Korea Aptamers Market Overview
• 14.2. South Korea Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Aptamers Market

• 15.1. Western Europe Aptamers Market Overview
• 15.2. Western Europe Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Aptamers Market

• 16.1. UK Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Aptamers Market

• 17.1. Germany Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Aptamers Market

• 18.1. France Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Aptamers Market

• 19.1. Italy Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Aptamers Market

• 20.1. Spain Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Aptamers Market

• 21.1. Eastern Europe Aptamers Market Overview
• 21.2. Eastern Europe Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Aptamers Market

• 22.1. Russia Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Aptamers Market

• 23.1. North America Aptamers Market Overview
• 23.2. North America Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Aptamers Market

• 24.1. USA Aptamers Market Overview
• 24.2. USA Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Aptamers Market

• 25.1. Canada Aptamers Market Overview
• 25.2. Canada Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Aptamers Market

• 26.1. South America Aptamers Market Overview
• 26.2. South America Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Aptamers Market

• 27.1. Brazil Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Aptamers Market

• 28.1. Middle East Aptamers Market Overview
• 28.2. Middle East Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Aptamers Market

• 29.1. Africa Aptamers Market Overview
• 29.2. Africa Aptamers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Aptamers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Aptamers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Aptamers Market Competitive Landscape And Company Profiles

• 30.1. Aptamers Market Competitive Landscape
• 30.2. Aptamers Market Company Profiles
  • 30.2.1. Aptamer Group Limited
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. SomaLogic Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Aptamer Sciences Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Aptagen LLC
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. NeoVentures Biotechnology Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Aptamers Market Competitive Benchmarking

32. Global Aptamers Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Aptamers Market

34. Aptamers Market Future Outlook and Potential Analysis

• 34.1 Aptamers Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Aptamers Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Aptamers Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer